Benzoyl peroxide/clindamycin - Stiefel Laboratories

Drug Profile

Benzoyl peroxide/clindamycin - Stiefel Laboratories

Alternative Names: Clindamycin/benzoyl peroxide - Stiefel; Duac

Latest Information Update: 25 Mar 2017

Price : $50

At a glance

  • Originator Stiefel Laboratories
  • Class Antiacnes; Antibacterials; Benzoic acids; Lincosamides; Oxidants; Small molecules
  • Mechanism of Action Keratinocyte inhibitors; Protein 50S ribosomal subunit inhibitors; Protein synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Acne vulgaris

Most Recent Events

  • 13 Oct 2016 No recent reports on development identified - Phase-III for Acne vulgaris in China (Topical)
  • 01 Apr 2013 Phase-III clinical trials in Acne vulgaris in China (Topical)
  • 01 Jan 2013 Launched prior to 2013 for Acne vulgaris in Canada, Latin America, Asia, Australia and New Zealand (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top